Terrance Adams, MBA, was named Chief Operating Officer of Vanderbilt Bedford Hospital. Adams began his new role on Sept. 9.
Adams has operational responsibility for the hospital that includes ensuring success through quality enhancement, cost containment, revenue growth and development of strong relationships with hospital staff, board members and community.
Sarah Allen, MBA, CNMT, RT(CT), associate operating officer for the Department of Radiology and Radiological Sciences, was named Senior Vice President for Radiology Services.
One of VUMC’s largest and most prolific departments, Radiology and Radiological Sciences is currently home to more than 140 faculty, 50 trainees and 500 staff, and is responsible for performing thousands of diagnostic imaging studies and radiologic procedures each day.
Alexander Bick, MD, PhD, a physician-scientist at VUMC who is internationally known for his research on the genetics of blood disorders, was named director of VUMC’s Division of Genetic Medicine, effective Oct. 1.
Bick succeeded Nancy Cox, PhD, the Mary Phillips Edmonds Gray Professor of Medicine, who has led Genetic Medicine since she was recruited to VUMC from the University of Chicago in 2015. Genetic Medicine is one of 13 divisions in the Department of Medicine.
Cox continues in her role as founding director of the Vanderbilt Genetics Institute, which fosters scientific interactions in genomic and genetic research across Vanderbilt University and VUMC.
Daniel Brown, MD, professor and interim chair of the Department of Radiology and Radiological Sciences, was named as the department’s permanent chair.
Brown, who is also a professor of Biomedical Engineering, had served as Radiology’s interim chair since the summer of 2023.
Mary-Margaret “Meg” Chren, MD, professor and chair of the Department of Dermatology and holder of the Robert N. and Rachelle Buchanan and A.H. and Lucile Lancaster Chair in Dermatology, retires from VUMC on Dec. 31. She will become a Visiting Scholar at Stanford University in the Center for Advanced Studies in the Behavioral Sciences.
Jessica Singh Delwadia, MBA, was named Vice President of Managed Care. She had been serving in this role in an interim capacity since April.
Delwadia is responsible for managed care contracting on behalf of the VUMC enterprise including the Medical Center’s clinical facilities, Vanderbilt Medical Group, along with its affiliates and joint ventures.
Roger Dmochowski, MD, MMHC, professor of Urology, Surgery, and Obstetrics & Gynecology and director of the Section of Female Pelvic Medicine, was promoted to Vice President and Executive Medical Director of Perioperative Services at VUMC.
Dmochowski is a key member and leader of the perioperative executive team that includes the associate nursing officer, associate surgeon-in-chief, executive vice chair of Anesthesiology, and associate operations officer for perioperative services.
Cathy Eng, MD, the David H. Johnson Professor of Surgical and Medical Oncology, was named associate director of Strategic Relations and Research Partnerships for Vanderbilt-Ingram Cancer Center.
In this new position she works to elevate Vanderbilt-Ingram’s profile locally, regionally, nationally and internationally through stakeholder engagement, programmatic development and targeted marketing. It is an expanded role for Eng, who has served as director for Strategic Relations and is an internationally known expert on colorectal cancer and early-onset cancers.
Anthony Flores, MD, MPH, PhD, joined Vanderbilt as director of the Division of Pediatric Infectious Diseases. Flores holds the Edward Claiborne Stahlman Chair.
Previously, Flores served as professor and chief of the Division of Pediatric Infectious Diseases at the McGovern Medical School of UTHealth Houston.
Tracy Frech, MD, MSCI, was named to direct the division of Rheumatology and Immunology in the Department of Medicine at VUMC. She succeeded Leslie Crofford, MD, Wilson Family Professor of Medicine, who led the division since 2014.
Sandra Gonzalez, MBA, JM, who had served as corporate director of Claims and Insurance Responsibilities at Baptist Health South Florida since 2011, was named Vice President, Risk and Insurance Management for VUMC.
The Office of Risk and Insurance Management supports the Medical Center’s missions through risk financing, risk prevention and risk control activities by taking responsibility for finding solutions to problems or complaints for all those seeking services at VUMC and continuously evaluating and improving the Medical Center’s performance.
Allison Hanlon, MD, PhD, MBA, associate professor of Dermatology, has been chosen to serve as the department’s interim chair, beginning Jan. 1, 2025. A national search will be conducted to identify Meg Chren’s permanent successor.
Anna Hemnes, MD, professor of Medicine, was named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.
The division is at the forefront of essential research in the field of respiratory diseases and provides robust clinical and research training. Division faculty members provide high-quality clinical care across a wide spectrum of diseases, helping patients manage conditions ranging from mild allergies to chronic lung disease.
Following an extensive national search, Karen Keady, PhD, RN, NEA-BC, Vice President and Chief Nurse Executive with the University of Rochester Medical Center, was named System Chief Nursing Officer for VUMC.
Keady succeeded Marilyn Dubree, MSN, RN, who retired from her responsibilities as Executive Chief Nursing Officer but remains with VUMC in a part-time role.
Lakmini Kidder, MBA, was appointed to the newly expanded role of Senior Vice President, Finance, and Chief Revenue Officer. She joined VUMC from Johns Hopkins Health System in Baltimore, where she served as Vice President of Enterprise Revenue Cycle Management.
In her new capacity, Kidder assumes responsibility for overseeing all aspects of VUMC’s integrated revenue cycle, encompassing hospitals, clinics, the Vanderbilt Medical Group and Vanderbilt Integrated Providers.
Sunil Kripalani, MD, MSc, a nationally recognized leader in patient-centered and health systems research, was named Vice President for Health System Sciences, effective March 1.
In his new role, Kripalani is helping lead and support activities by VUMC, as an academic learning health system, to implement and evaluate innovations in patient care and population health and to expand broader efforts at the intersection of research and clinical operations.
Tanmay Mathur, MS, MBA, was named Vice President for the Vanderbilt Psychiatric Hospital. Mathur succeeded Mary Pawlikowski, MA, MEd, PsyD (ABD), who retired from VPH and Vanderbilt Behavioral Health.
William Obremskey, MD, MPH, MMHC, professor of Orthopaedic Surgery, was named executive medical director of Vanderbilt Supply Chain Services. Obremskey also serves as the Orthopaedic Trauma Research and Fellowship director.
As the executive medical director of VUMC Supply Chain, Obremskey provides medical leadership facilitating faculty, clinical and leadership interactions with the Supply Chain to assure patient-centered practices and effective and efficient delivery of patient care.
Scott Peterson was appointed President of Vanderbilt Stallworth Rehabilitation Hospital. In his position, Peterson oversees the day-to-day operations of the 80-bed hospital, including the provision of high-quality patient care.
After 35 years of tireless service to the people and patients of VUMC, C. Wright Pinson, MBA, MD, Deputy CEO and Chief Health System Officer, will step down from that role on June 30, 2025, at the end of the current fiscal year.
Jane Freedman, MD, chair of the Department of Medicine, and physician-in-chief of Vanderbilt University Hospital, will be Pinson’s successor. Pinson will continue as President of the Vanderbilt Health Affiliated Network and serve as a senior counselor to the CEO of VUMC dealing with government affairs, external hospital organizations and community affairs.
Peter Reese, MD, PhD, was named the inaugural director of the Vanderbilt Center for Transplant Science. Reese is a board-certified transplant nephrologist and epidemiologist.
The Vanderbilt Center for Transplant Science was created to save the lives of patients waiting for a transplant and improve the outcomes for patients after they receive a transplant.
Michael Regier, JD, general counsel and secretary at VUMC, retired at the end of the academic year. Douglas Mefford, JD, managing counsel in the Office of Legal Affairs, succeeded him.
Douglas Ruderfer, PhD, whose research at VUMC explores the intersection of genomics, biomedical informatics and psychiatry, was named director of a newly established Center for Digital Genomic Medicine.
By integrating clinical, genomic and digital device data, and by developing novel methodologies and infrastructure, the center aims to generate the evidence needed to improve patient outcomes and support clinical decision-making.
David Russell, Senior Vice President for Business Development, was promoted to Executive Vice President for Organization Transformation and Chief Strategic Business Development Officer.
Since joining VUMC in 2022, Russell has contributed significantly to the institution’s business development initiatives. In this role, he oversees VUMC’s enterprise-wide internal and external business development, market positioning and growth strategies, as well as strategic transactions such as mergers, acquisitions and other affiliations. Russell also oversees VUMC’s Health Professional Services team.
C.J. Stimson, MD, JD, assistant professor of Urology and Senior Vice President of Value Transformation in the Office of Population Health, was named Executive Vice President for Population Health.
Stimson succeeded David Posch, MA, who transitioned to the role of Senior Vice President for Business Development.
